Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,841 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inactivated and adjuvanted whole-virion clade 2.3.4 H5N1 pre-pandemic influenza vaccine possesses broad protective efficacy against infection by heterologous clades of highly pathogenic H5N1 avian influenza virus in mice.
Harada Y, Ninomiya-Mori A, Takahashi Y, Shirakura M, Kishida N, Kageyama T, Tada Y, Tashiro M, Odagiri T. Harada Y, et al. Vaccine. 2011 Oct 26;29(46):8330-7. doi: 10.1016/j.vaccine.2011.08.091. Epub 2011 Sep 10. Vaccine. 2011. PMID: 21911027
Anti-influenza activity of phenethylphenylphthalimide analogs derived from thalidomide.
Iwai Y, Takahashi H, Hatakeyama D, Motoshima K, Ishikawa M, Sugita K, Hashimoto Y, Harada Y, Itamura S, Odagiri T, Tashiro M, Sei Y, Yamaguchi K, Kuzuhara T. Iwai Y, et al. Among authors: harada y. Bioorg Med Chem. 2010 Jul 15;18(14):5379-90. doi: 10.1016/j.bmc.2010.05.035. Epub 2010 May 20. Bioorg Med Chem. 2010. PMID: 20538468
Influenza gain-of-function experiments: their role in vaccine virus recommendation and pandemic preparedness.
Schultz-Cherry S, Webby RJ, Webster RG, Kelso A, Barr IG, McCauley JW, Daniels RS, Wang D, Shu Y, Nobusawa E, Itamura S, Tashiro M, Harada Y, Watanabe S, Odagiri T, Ye Z, Grohmann G, Harvey R, Engelhardt O, Smith D, Hamilton K, Claes F, Dauphin G. Schultz-Cherry S, et al. Among authors: harada y. mBio. 2014 Dec 12;5(6):e02430-14. doi: 10.1128/mBio.02430-14. mBio. 2014. PMID: 25505124 Free PMC article.
Systematic evaluation of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for preparing influenza vaccine seed virus.
Nakamura K, Harada Y, Takahashi H, Trusheim H, Bernhard R, Hamamoto I, Hirata-Saito A, Ogane T, Mizuta K, Konomi N, Konomi Y, Asanuma H, Odagiri T, Tashiro M, Yamamoto N. Nakamura K, et al. Among authors: harada y. Vaccine. 2019 Oct 8;37(43):6526-6534. doi: 10.1016/j.vaccine.2019.08.064. Epub 2019 Sep 6. Vaccine. 2019. PMID: 31500967 Free article.
Establishment of Reference Reagents for Single-Radial-Immunodiffusion Assay on the 2022/23 Seasonal Influenza Vaccine in Japan and Their Quality Validation.
Shimasaki N, Kuwahara T, Nishijima H, Nakamura K, Sato K, Murano K, Itamura S, Akahori Y, Takashita E, Kishida N, Arita T, Nakauchi M, Takeda M, Hasegawa H, Ryo A, Harada Y. Shimasaki N, et al. Among authors: harada y. Jpn J Infect Dis. 2024 Mar 21;77(2):105-111. doi: 10.7883/yoken.JJID.2023.218. Epub 2023 Nov 30. Jpn J Infect Dis. 2024. PMID: 38030271 Free article.
Evaluation of a qualified MDCK cell line for virus isolation to develop cell-based influenza vaccine viruses with appropriate antigenicity.
Harada Y, Takahashi H, Fujimoto T, Horikoshi F, Chida S, Tanaka K, Minari K, Tanimoto Y, Fujisaki S, Miura H, Nakauchi M, Shimasaki N, Suzuki Y, Arita T, Hamamoto I, Yamamoto N, Hasegawa H, Odagiri T, Tashiro M, Nobusawa E. Harada Y, et al. Vaccine. 2024 Oct 3;42(23):126242. doi: 10.1016/j.vaccine.2024.126242. Epub 2024 Aug 29. Vaccine. 2024. PMID: 39213922
2,841 results